Whelan, C., Coelho, T., Conceicao, I., Brannagan Iii, T. H., Wang, A. K., Polydefkis, M. J., Dyck, P. J., Berk, J. L., Obici, L., Kristen, A., Narayana, A., Olugemo, K., Aquino, P., Benson, M. D., & Gertz, M. (2021). Long-term efficacy and safety of inotersen in patients with hereditary transthyretin amyloid polyneuropathy with or without cardiomyopathy: post hoc analysis of NEURO-TTR open-label extension. European Heart Journal, 42(Supplement_1). https://doi.org/10.1093/eurheartj/ehab724.2745